CVE:MFS

Medifocus Inc. (MFS.V) Competitors

C$0.01
0.00 (0.00 %)
(As of 09/4/2020)
Add
Compare
Today's Range
C$0.01
Now: C$0.01
C$0.01
50-Day Range
C$0.01
MA: C$0.01
C$0.01
52-Week Range
C$0.01
Now: C$0.01
C$0.02
Volume26,000 shs
Average Volume317,764 shs
Market CapitalizationC$1.85 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Medifocus Inc. (MFS.V) (CVE:MFS) Vs. RVV, COT, PBS, CHV, PREV, and COM

Should you be buying MFS stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Medifocus Inc. (MFS.V), including Revive Therapeutics (RVV), Cotinga Pharmaceuticals Inc. (COT.V) (COT), Pacgen Life Science Co. (PBS.V) (PBS), (CHV) (CHV), (PREV) (PREV), and 138267 (COM.TO) (COM).

Revive Therapeutics (CVE:RVV) and Medifocus Inc. (MFS.V) (CVE:MFS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Valuation and Earnings

This table compares Revive Therapeutics and Medifocus Inc. (MFS.V)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revive TherapeuticsN/AN/AN/AC($0.02)-3.64
Medifocus Inc. (MFS.V)C$2.23 million0.83C$-1,849,840.00C($0.01)-1.00

Revive Therapeutics has higher earnings, but lower revenue than Medifocus Inc. (MFS.V). Revive Therapeutics is trading at a lower price-to-earnings ratio than Medifocus Inc. (MFS.V), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations for Revive Therapeutics and Medifocus Inc. (MFS.V), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Revive Therapeutics0000N/A
Medifocus Inc. (MFS.V)0000N/A

Profitability

This table compares Revive Therapeutics and Medifocus Inc. (MFS.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Revive TherapeuticsN/AN/AN/A
Medifocus Inc. (MFS.V)N/AN/AN/A

Summary

Medifocus Inc. (MFS.V) beats Revive Therapeutics on 3 of the 3 factors compared between the two stocks.

Cotinga Pharmaceuticals Inc. (COT.V) (CVE:COT) and Medifocus Inc. (MFS.V) (CVE:MFS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Valuation and Earnings

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and Medifocus Inc. (MFS.V)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/AC($0.12)-0.30
Medifocus Inc. (MFS.V)C$2.23 million0.83C$-1,849,840.00C($0.01)-1.00

Cotinga Pharmaceuticals Inc. (COT.V) has higher earnings, but lower revenue than Medifocus Inc. (MFS.V). Medifocus Inc. (MFS.V) is trading at a lower price-to-earnings ratio than Cotinga Pharmaceuticals Inc. (COT.V), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations for Cotinga Pharmaceuticals Inc. (COT.V) and Medifocus Inc. (MFS.V), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cotinga Pharmaceuticals Inc. (COT.V)0000N/A
Medifocus Inc. (MFS.V)0000N/A

Profitability

This table compares Cotinga Pharmaceuticals Inc. (COT.V) and Medifocus Inc. (MFS.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cotinga Pharmaceuticals Inc. (COT.V)N/AN/AN/A
Medifocus Inc. (MFS.V)N/AN/AN/A

Summary

Medifocus Inc. (MFS.V) beats Cotinga Pharmaceuticals Inc. (COT.V) on 2 of the 3 factors compared between the two stocks.

Pacgen Life Science Co. (PBS.V) (CVE:PBS) and Medifocus Inc. (MFS.V) (CVE:MFS) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Valuation and Earnings

This table compares Pacgen Life Science Co. (PBS.V) and Medifocus Inc. (MFS.V)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Pacgen Life Science Co. (PBS.V)C$302,079.006.44C$-388,896.00C($0.01)-5.00
Medifocus Inc. (MFS.V)C$2.23 million0.83C$-1,849,840.00C($0.01)-1.00

Pacgen Life Science Co. (PBS.V) has higher earnings, but lower revenue than Medifocus Inc. (MFS.V). Pacgen Life Science Co. (PBS.V) is trading at a lower price-to-earnings ratio than Medifocus Inc. (MFS.V), indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations for Pacgen Life Science Co. (PBS.V) and Medifocus Inc. (MFS.V), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Pacgen Life Science Co. (PBS.V)0000N/A
Medifocus Inc. (MFS.V)0000N/A

Profitability

This table compares Pacgen Life Science Co. (PBS.V) and Medifocus Inc. (MFS.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Pacgen Life Science Co. (PBS.V)N/AN/AN/A
Medifocus Inc. (MFS.V)N/AN/AN/A

Summary

Pacgen Life Science Co. (PBS.V) beats Medifocus Inc. (MFS.V) on 3 of the 5 factors compared between the two stocks.

(CHV) (CNSX:CHV) and Medifocus Inc. (MFS.V) (CVE:MFS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Valuation and Earnings

This table compares (CHV) and Medifocus Inc. (MFS.V)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CHV)N/AN/AN/AN/AN/A
Medifocus Inc. (MFS.V)C$2.23 million0.83C$-1,849,840.00C($0.01)-1.00

(CHV) has higher earnings, but lower revenue than Medifocus Inc. (MFS.V).

Analyst Ratings

This is a summary of current recommendations for (CHV) and Medifocus Inc. (MFS.V), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CHV)0000N/A
Medifocus Inc. (MFS.V)0000N/A

Profitability

This table compares (CHV) and Medifocus Inc. (MFS.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CHV)N/AN/AN/A
Medifocus Inc. (MFS.V)N/AN/AN/A

Summary

Medifocus Inc. (MFS.V) beats (CHV) on 1 of the 1 factors compared between the two stocks.

(PREV) (CNSX:PREV) and Medifocus Inc. (MFS.V) (CVE:MFS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, earnings, profitability and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for (PREV) and Medifocus Inc. (MFS.V), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(PREV)0000N/A
Medifocus Inc. (MFS.V)0000N/A

Profitability

This table compares (PREV) and Medifocus Inc. (MFS.V)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(PREV)N/AN/AN/A
Medifocus Inc. (MFS.V)N/AN/AN/A

Valuation and Earnings

This table compares (PREV) and Medifocus Inc. (MFS.V)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(PREV)N/AN/AN/AN/AN/A
Medifocus Inc. (MFS.V)C$2.23 million0.83C$-1,849,840.00C($0.01)-1.00

(PREV) has higher earnings, but lower revenue than Medifocus Inc. (MFS.V).

Summary

Medifocus Inc. (MFS.V) beats (PREV) on 1 of the 1 factors compared between the two stocks.

Medifocus Inc. (MFS.V) (CVE:MFS) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Analyst Recommendations

This is a summary of current ratings for Medifocus Inc. (MFS.V) and 138267 (COM.TO), as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medifocus Inc. (MFS.V)0000N/A
138267 (COM.TO)0000N/A

Profitability

This table compares Medifocus Inc. (MFS.V) and 138267 (COM.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medifocus Inc. (MFS.V)N/AN/AN/A
138267 (COM.TO)N/AN/AN/A

Earnings & Valuation

This table compares Medifocus Inc. (MFS.V) and 138267 (COM.TO)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medifocus Inc. (MFS.V)C$2.23 million0.83C$-1,849,840.00C($0.01)-1.00
138267 (COM.TO)N/AN/AN/AN/AN/A

138267 (COM.TO) has lower revenue, but higher earnings than Medifocus Inc. (MFS.V).

Summary

Medifocus Inc. (MFS.V) beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.


Medifocus Inc. (MFS.V) Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
RVV
Revive Therapeutics
0.5$0.08flatC$3.62 millionN/A-3.64High Trading Volume
News Coverage
Gap Down
COT
Cotinga Pharmaceuticals Inc. (COT.V)
0.5$0.04flatC$1.54 millionN/A-0.30Upcoming Earnings
Gap Up
PBS
Pacgen Life Science Co. (PBS.V)
0.6$0.03flatC$1.30 millionC$302,079.00-5.00Gap Down
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
News Coverage
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
HALO
Halozyme Therapeutics
1.3$46.18flatC$0.00C$267.59 million50.75News Coverage
LTY
Liberty Biopharma
0.6$2.00flatC$0.00N/A-12.66Gap Down
MMJ
Matica Enterprises
0.5N/AN/AC$0.00N/A0.00High Trading Volume
News Coverage
SCYB
Scythian Biosciences
0.5$3.49flatC$0.00N/A0.00High Trading Volume
ABCN
VIVO Cannabis
0.6$1.32flatC$0.00N/A0.00Gap Down
VP
Vodis Pharmaceuticals
0.6N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.